CRWV 10-Q report for 2026-03-31

CoreWeave, Inc. (CRWV) — Form 10‑Q for quarter ended March 31, 2026. Filing excerpt includes cover page, table of contents, forward‑looking statement caution and condensed consolidated financial statements (balance sheet, statement of operations, equity rollforward).

The provided excerpt of CoreWeave’s Form 10‑Q for the quarter ended March 31, 2026 contains the filing cover page, a table of contents, the standard forward‑looking statements disclosure and key condensed consolidated financial statements. Reported amounts (in millions) include: revenue $2,078; cost of revenue $716; total operating expenses $2,222; operating loss $144; interest expense, net $536; provision for income taxes $84; net loss $740; total assets $55,573; total liabilities $50,814; cash and cash equivalents $2,244; property and equipment, net $36,424. The filing also discloses shares outstanding as of April 30, 2026: 447,573,939 Class A; 97,996,407 Class B. The excerpt does not include the complete MD&A, full notes, risk factor updates, detailed liquidity discussion, or management commentary that would enable a higher‑confidence directional trade recommendation. As such, the document is primarily confirmation that the 10‑Q was filed and provides headline financials and capital structure data; it is actionable only to the extent investors incorporate these reported figures and the company’s forward‑looking caution into their existing views. No additional facts beyond the filing excerpt have been added.

This excerpt is only the cover page/header of Sleep Number’s Form 10‑Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high‑confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As‑is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

This excerpt is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk‑factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital‑structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover‑page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk‑factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.